Author:
Kawahara Masaaki,Tada Harue,Tokoro Akihiro,Teramukai Satoshi,Origasa Hideki,Kubota Kaoru,Shinkai Tetsu,Fukushima Masanori,Furuse Kiyoyuki
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Genetics,Oncology
Reference17 articles.
1. Natale RB: Experience with new chemotherapeutic agents in non-small cell lung cancer. Chest. 1998, 113: 32S-39S. 10.1378/chest.113.1_Supplement.32S.
2. Ries LAG, Eisner MP, Kosary Cl, (editors), et al: SEER Cancer Statistics Review, 1973-1999. 2002, Bethesda, MD: National Cancer Institute, [ http://seer.cancer.gov/csr/1973_1999/ ]
3. Bunn PA, Vokes EE, Langer CJ, Schiller JH: An update on North American randomized studies in non-small cell lung cancer. Semin Oncol. 1998, 25: S2-S10.
4. Bulzebruck H, Bopp R, Drings P, Bauer E, Krysa S, Probst G, van Kaick G, Muller KM, Vogt-Moykopf I: New aspects in staging of lung cancer. Prospective validation of the International Union Against Cancer TNM classification. Cancer. 1992, 70: 1102-1110. 10.1002/1097-0142(19920901)70:5<1102::AID-CNCR2820700514>3.0.CO;2-5.
5. Thongprasert S, Sanguanmitra P, Juthapan W, Clinch J: Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy. Lung Cancer. 1999, 24: 17-24. 10.1016/S0169-5002(99)00017-3.